TAMMY WATZ: Open Payments
NPI 1780795658 · SULLIVAN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 41 payments from 18 companies in 2025. Trend: 2023 $1,105 · 2024 $792 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $269 |
| PFIZER INC. | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| Exact Sciences Corporation | 2 | $35 |
| Radius Health, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $26 |
| Abbott Laboratories | 1 | $23 |
| Viatris Specialty LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: UBRELVY, VRAYLAR, QULIPTA, VYNDAQEL, Tymlos, TRELEGY ELLIPTA, NURTEC ODT, MOUNJARO.
Industry payments across MO — which companies pay providers there.
